Azathioprine hypersensitivity syndrome manifesting as subcutaneous Sweet syndrome and acute pancreatitis.


Journal

Journal of cutaneous pathology
ISSN: 1600-0560
Titre abrégé: J Cutan Pathol
Pays: United States
ID NLM: 0425124

Informations de publication

Date de publication:
Feb 2023
Historique:
revised: 03 08 2022
received: 25 01 2022
accepted: 15 08 2022
pubmed: 20 8 2022
medline: 24 1 2023
entrez: 19 8 2022
Statut: ppublish

Résumé

Azathioprine (AZA) is a commonly used immunosuppressive therapy that has been implicated in a number of cutaneous and systemic inflammatory reactions. Initiation of AZA has been associated with a hypersensitivity syndrome manifesting as acute pancreatitis and Sweet syndrome. Subcutaneous Sweet syndrome is a rare variant of Sweet syndrome where the dominant localization of inflammation is within the subcutaneous fat; it is commonly associated with underlying myeloproliferative disease. However, it has not been reported in the literature as a cutaneous manifestation of AZA hypersensitivity syndrome. We present a unique case of acute pancreatitis and biopsy-proven subcutaneous Sweet syndrome following the initiation of AZA with resolution upon discontinuation.

Identifiants

pubmed: 35983669
doi: 10.1111/cup.14315
doi:

Substances chimiques

Azathioprine MRK240IY2L
Immunosuppressive Agents 0

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

127-130

Informations de copyright

© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Teich N, Mohl W, Bokemeyer B, et al. Azathioprine-induced acute pancreatitis in patients with inflammatory bowel diseases-a prospective study on incidence and severity. J Crohns Colitis. 2016;10(1):61-68. doi:10.1093/ecco-jcc/jjv188
Bidinger JJ, Sky K, Battafarano DF, Henning JS. The cutaneous and systemic manifestations of azathioprine hypersensitivity syndrome. J Am Acad Dermatol. 2011;65(1):184-191. doi:10.1016/j.jaad.2010.04.041
Patel AA, Swerlick RA, McCall CO. Azathioprine in dermatology: the past, the present, and the future. J Am Acad Dermatol. 2006;55(3):369-389. doi:10.1016/j.jaad.2005.07.059
Maltzman JS, Koretzky GA. Azathioprine: old drug, new actions. J Clin Invest. 2003;111(8):1122-1124. doi:10.1172/JCI18384
Jr CCC, Lessner HE, Larsen WE. Azathioprine therapy of “autoimmune” diseases. Am J Med. 1966;41:404-412. doi:10.1016/0002-9343(66)90086-6
Cyrus N, Stavert R, Mason AR. Neutrophilic dermatosis after azathioprine exposure. JAMA Dermatol. 2013;149(5):592-597.
Lai SW, Wang YC, Wang CH, Huang TY. Acute pancreatitis and erythema nodosum associated with azathioprine. QJM. 2012;105(4):363-364. doi:10.1093/qjmed/hcr041
Cohen PR. Sweet's syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis. 2007;2:34. doi:10.1016/j.jaad.2005.03.001
Hasegawa M, Sato S, Nakada M, et al. Sweet's syndrome associated with granulocyte colony-stimulating factor. Eur J Dermatol. 1998;8:503-505.
Sutra-Loubet C, As C, Guillemette J, Wallach D. Neutrophilic panniculitis. J Am Acad Dermatol. 2004;50:280-285. doi:10.1016/j.jaad.2003.10.006
Cohen PR. Subcutaneous Sweet's syndrome: a variant of acute febrile neutrophilic dermatosis that is included in the histopathologic differential diagnosis of neutrophilic panniculitis. J Am Acad Dermatol. 2005;52(5):927-928. doi:10.1016/j.jaad.2005.03.001
Kirkland EB, Sachdev R, Kim J, Peng D. Early pancreatic panniculitis associated with HELLP syndrome and acute fatty liver of pregnancy. J Cutan Pathol. 2011;38(10):814-817. doi:10.1111/j.1600-0560.2011.01742.x
Heath MS, Ortega-Loayza AG. Insights into the pathogenesis of Sweet's syndrome. Front Immunol. 2019;10:414. doi:10.3389/fimmu.2019.00414
Sturdevant RAL, Singleton JW, Deren JJ, Law DH, McCleery JL. Azathioprine-related pancreatitis in patients with Crohn's disease. Gastroenterology. 1979;77(4):883-886. doi:10.1016/0016-5085(79)90387-1
Seo D, Suh H, Lee JK, et al. Estrogen-induced acute pancreatitis: a case report and literature review. Obstet Gynecol Sci. 2017;60(5):485-489. doi:10.5468/ogs.2017.60.5.485
Chan MP, Duncan LM, Nazarian RM. Subcutaneous Sweet syndrome in the setting of myeloid disorders: a case series and review of the literature. J Am Acad Dermatol. 2013;68(6):1006-1015. doi:10.1016/j.jaad.2012.12.954
Tran T-AN, DuPree M, Carlson JA. Neutrophilic lobular (pustular) panniculitis associated with rheumatoid arthritis. Am J Dermatopathol. 1999;21(9):247-252.
Dahl PR, Su WPD, Cullimore KC, Dicken CH. Pancreatic panniculitis. J Am Acad Dermatol. 1995;33(3):413-417. doi:10.1016/0190-9622(95)91385-8

Auteurs

Jacob L Thomas (JL)

Weill Cornell Medical College, New York, New York, USA.

Michael W Tee (MW)

Department of Dermatology, Weill Cornell Medicine, New York, New York, USA.

Joanna Harp (J)

Department of Dermatology, Weill Cornell Medicine, New York, New York, USA.

Cynthia Magro (C)

Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH